Network pharmacology-based strategy for predicting active ingredients and potential targets of Yangxinshi tablet for treating heart failure

被引:71
|
作者
Chen, Langdong [1 ]
Cao, Yan [1 ]
Zhang, Hai [2 ]
Lv, Diya [1 ]
Zhao, Yahong [3 ]
Liu, Yanjun [3 ]
Ye, Guan [3 ]
Chai, Yifeng [1 ]
机构
[1] Second Mil Med Univ, Sch Pharm, Shanghai 200433, Peoples R China
[2] Tongji Univ, Shanghai Matern & Infant Hosp 1, Sch Med, Dept Pharm, Shanghai 201204, Peoples R China
[3] Shanghai Pharmaceut Holding Co Ltd, Cent Res Inst, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Yangxinshi tablet; Network pharmacology; Heart failure; CONVERTING ENZYME-INHIBITORS; NF-KAPPA-B; PPAR-GAMMA; PROTEIN; DIFFERENTIATION; MECHANISM; APOPTOSIS; FORMULA; AGENTS; MAPK;
D O I
10.1016/j.jep.2017.12.011
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Yangxinshi tablet (YXST) is an effective treatment for heart failure and myocardial infarction; it consists of 13 herbal medicines formulated according to traditional Chinese Medicine (TCM) practices. It has been used for the treatment of cardiovascular disease for many years in China. Materials and methods: In this study, a network pharmacology-based strategy was used to elucidate the mechanism of action of YXST for the treatment of heart failure. Cardiovascular disease-related protein target and compound databases were constructed for YXST. A molecular docking platform was used to predict the protein targets of YXST. The affinity between proteins and ingredients was determined using surface plasmon resonance (SPR) assays. The action modes between targets and representative ingredients were calculated using Glide docking, and the related pathways were predicted using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Results: A protein target database containing 924 proteins was constructed; 179 compounds in YXST were identified, and 48 compounds with high relevance to the proteins were defined as representative ingredients. Thirty-four protein targets of the 48 representative ingredients were analyzed and classified into two categories: immune and cardiovascular systems. The SPR assay and molecular docking partly validated the interplay between protein targets and representative ingredients. Moreover, 28 pathways related to heart failure were identified, which provided directions for further research on YXST. Conclusions: This study demonstrated that the cardiovascular protective effect of YXST mainly involved the immune and cardiovascular systems. Through the research strategy based on network pharmacology, we analysis the complex system of YXST and found 48 representative compounds, 34 proteins and 28 related pathways of YXST, which could help us understand the underlying mechanism of YSXT's anti-heart failure effect. The network-based investigation could help researchers simplify the complex system of YXSY. It may also offer a feasible approach to decipher the chemical and pharmacological bases of other TCM formulas.
引用
收藏
页码:359 / 368
页数:10
相关论文
共 50 条
  • [31] Network Pharmacology-Based Strategy to Investigate the Mechanisms of Cibotium barometz in Treating Osteoarthritis
    Chen, Guang-Yao
    Wang, Yi-Fei
    Yu, Xin-Bo
    Liu, Xiao-Yu
    Chen, Jia-Qi
    Luo, Jing
    Tao, Qing-Wen
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [32] Network Pharmacology-Based Strategy to Investigate the Mechanisms of Cibotium barometz in Treating Osteoarthritis
    Chen, Guang-Yao
    Wang, Yi-Fei
    Yu, Xin-Bo
    Liu, Xiao-Yu
    Chen, Jia-Qi
    Luo, Jing
    Tao, Qing-Wen
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [33] Systems pharmacology-based dissection of the active ingredients and targets of Yiqi Zishen formula for application to COPD
    Li, Jiansheng
    Zhao, Peng
    Tian, Yange
    Li, Ya
    Feng, Suxiang
    Wang, Yonghua
    Guo, Zihu
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (08): : 12825 - 12844
  • [34] Network Pharmacology-Based Strategy for Predicting Therapy Targets of Traditional Chinese Medicine Xihuang Pill on Liver Cancer
    Zhao, Xu
    Hao, Jian
    Chen, Sinuan
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [35] A network pharmacology approach to discover action mechanisms of Yangxinshi Tablet for improving energy metabolism in chronic ischemic heart failure
    Wu, Ruo-ming
    Jiang, Bing
    Li, Hui
    Dang, Wen-zhen
    Bao, Wei-Lian
    Li, Hai-Dong
    Ye, Guan
    Shen, Xiaoyan
    [J]. JOURNAL OF ETHNOPHARMACOLOGY, 2020, 246
  • [36] Network Pharmacology-Based Approach to Investigate the Molecular Targets of Sinomenine for Treating Breast Cancer
    Li, Xiao-Mei
    Li, Mao-Ting
    Jiang, Ni
    Si, Ya-Chen
    Zhu, Meng-Mei
    Wu, Qiao-Yuan
    Shi, Dong-Chen
    Shi, Hui
    Luo, Qing
    Yu, Bing
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 1189 - 1204
  • [37] Network pharmacology-based screening of the active ingredients and potential targets of the genus of Pithecellobium marthae (Britton & Killip) Niezgoda & Nevl for application to Alzheimer's disease
    Zhang, Han
    Yan, Zhi-Yang
    Wang, Yu-Xi
    Bai, Ming
    Wang, Xiao-Bo
    Huang, Xiao-Xiao
    Song, Shao-Jiang
    [J]. NATURAL PRODUCT RESEARCH, 2019, 33 (16) : 2368 - 2371
  • [38] Systems pharmacology-based approach for dissecting the active ingredients and potential targets of the Chinese herbal Bufei Jianpi formula for the treatment of COPD
    Zhao, Peng
    Li, Jiansheng
    Li, Ya
    Tian, Yange
    Wang, Yonghua
    Zheng, Chunli
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 2633 - 2656
  • [39] Network Pharmacology-Based Approach Uncovers the Mechanism of GuanXinNing Tablet for Treating Thrombus by MAPKs Signal Pathway
    Wang, Mu-Lan
    Yang, Qin-Qin
    Ying, Xu-Hui
    Li, Yuan-Yuan
    Wu, Yang-Sheng
    Shou, Qi-Yang
    Ma, Quan-Xin
    Zhu, Zi-Wei
    Chen, Min-Li
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [40] A Comprehensive Network Pharmacology-Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer
    Zhuang, Zhenjie
    Chen, Qianying
    Huang, Cihui
    Wen, Junmao
    Huang, Haifu
    Liu, Zhanhua
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020